Investigating In silico and In vitro Therapeutic Potential of Diosmetin as the Anti-Parkinson Agent
Diosmetin possibly acts on several target receptors linked to the pathophysiology of PD, demonstrating promise as an OS inhibitor and scavenger.
Authors
- Rajnish Srivastava (ORCID: https://orcid.org/0000-0002-5988-9858)
- Jeetendra Kumar Gupta (ORCID: https://orcid.org/0000-0002-5819-371X)
- Krishna Kumar Varshney (ORCID: https://orcid.org/0000-0002-1051-4115)
Institutions
- Chitkara University (IN)
- GLA University (IN)
Publication Details
- Journal
- Protein and Peptide Letters
- Published
- 2024-09-26
- DOI
- https://doi.org/10.2174/0109298665333333240909104354
- Citations
- 1
- Primary Topic
- Nuclear Receptors and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.27